SCN5A and familial long QT syndrome: Mutations in SCN5A can cause various cardiac disorders including LQTS and Brugada syndrome and the channel is the molecular target of antiarrhythmics, local anesthetics, and various off-mark medicines that may cause drug-induced LQTS [29], [30].